+79.6%
CME vs BBIO
+42.7%
+36.9%
-31.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | -0.1% | +0.6% | +0.5% |
| 7D | -1.6% | -3.2% | +1.6% | -1.6% |
| 30D | +5.6% | -13.6% | +19.2% | +5.6% |
| 3M | +5.6% | +7.2% | -1.6% | +5.5% |
| 6M | -8.3% | +1.5% | -9.7% | -8.3% |
| YTD | +4.3% | -5.3% | +9.6% | +4.3% |
| 1Y | +9.1% | +37.7% | -28.6% | +8.8% |
| 3Y | +52.1% | +153.9% | -101.9% | +50.8% |
| All | +79.6% | +42.7% | +36.9% | +72.3% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling